Skip to search formSkip to main contentSkip to account menu

afoxolaner 136 MG Chewable Tablet [NexGard]

Known as: NexGard 136 MG Chewable Tablet, afoxolaner 136 mg ORAL TABLET, CHEWABLE [NexGard] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Twelve healthy dogs were included in this laboratory efficacy study. Six dogs were randomly allocated based on body weight to an… 
2018
2018
The efficacy of NexGard® and NexGard Spectra® against sarcoptic mange in dogs was evaluated in a clinical field study. Skin… 
2017
2017
The efficacy of a monthly oral endectocide product, NexGard Spectra® (Merial), a combination of afoxolaner and milbemycin oxime… 
2016
2016
BackgroundThe efficacy of a single 2.5 mg/kg dose of afoxolaner (NexGard®, Merial) against induced Otodectes cynotis infestations… 
2016
2016
BackgroundThe ability of the topical spot-on Advantix® (50 % permethrin/10 % imidacloprid) to prevent transmission of Ehrlichia… 
2015
2015
Because of their convenience, oral dosage forms are an emerging trend in companion animal formulations. Ectoparasiticides… 
2014
2014
BackgroundCanine babesiosis due to Babesia canis is an endemic disease in many European countries. A vaccine is available in some…